OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oestrogens, prolactin, hypothalamic-pituitary-gonadal axis, and schizophrenic psychoses
Anita Riecher‐Rössler
The Lancet Psychiatry (2016) Vol. 4, Iss. 1, pp. 63-72
Closed Access | Times Cited: 141

Showing 1-25 of 141 citing articles:

Sex and gender differences in mental disorders
Anita Riecher‐Rössler
The Lancet Psychiatry (2016) Vol. 4, Iss. 1, pp. 8-9
Closed Access | Times Cited: 466

Sex and gender differences in schizophrenic psychoses—a critical review
Anita Riecher‐Rössler, Surina Butler, Jayashri Kulkarni
Archives of Women s Mental Health (2018) Vol. 21, Iss. 6, pp. 627-648
Closed Access | Times Cited: 196

Sex differences in schizophrenia, bipolar disorder, and post‐traumatic stress disorder: Are gonadal hormones the link?
Andrea Gogos, Luke J. Ney, Natasha Seymour, et al.
British Journal of Pharmacology (2019) Vol. 176, Iss. 21, pp. 4119-4135
Open Access | Times Cited: 158

Promoting good mental health over the menopause transition
Lydia Brown, Myra S. Hunter, Rong Chen, et al.
The Lancet (2024) Vol. 403, Iss. 10430, pp. 969-983
Closed Access | Times Cited: 44

The Role of Estrogen Receptors and Their Signaling across Psychiatric Disorders
Wu Jeong Hwang, Tae Young Lee, Nahrie Suk Kim, et al.
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 373-373
Open Access | Times Cited: 129

Estrogens and SERMS as adjunctive treatments for schizophrenia
Jayashri Kulkarni, Surina Butler, Anita Riecher‐Rössler
Frontiers in Neuroendocrinology (2019) Vol. 53, pp. 100743-100743
Closed Access | Times Cited: 81

Estrogens in schizophrenia: progress, current challenges and opportunities
Bodyl A. Brand, Janna N. de Boer, Iris E. Sommer
Current Opinion in Psychiatry (2021) Vol. 34, Iss. 3, pp. 228-237
Open Access | Times Cited: 75

Antipsychotic medication for women with schizophrenia spectrum disorders
Bodyl A. Brand, Yudith R. A. Haveman, Franciska de Beer, et al.
Psychological Medicine (2021) Vol. 52, Iss. 4, pp. 649-663
Open Access | Times Cited: 68

Women with Schizophrenia-Spectrum Disorders After Menopause: A Vulnerable Group for Relapse
Iris E. Sommer, Bodyl A. Brand, Shiral S. Gangadin, et al.
Schizophrenia Bulletin (2022) Vol. 49, Iss. 1, pp. 136-143
Open Access | Times Cited: 42

Obesity as pleiotropic risk state for metabolic and mental health throughout life
Michael Leutner, Elma Dervić, Luise Bellach, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 41

Psychoneuroendocrinology
Luca Sforzini, Frances Isabella Weston, Carmine M. Pariante
American Psychiatric Association Publishing eBooks (2024)
Closed Access | Times Cited: 11

Estrogen and psychosis — a review and future directions
Eveline Mu, Caroline Gurvich, Jayashri Kulkarni
Archives of Women s Mental Health (2024)
Open Access | Times Cited: 10

Predictors of Transition to Psychosis in Individuals at Clinical High Risk
Jean Addington, Megan S. Farris, Jacqueline Stowkowy, et al.
Current Psychiatry Reports (2019) Vol. 21, Iss. 6
Closed Access | Times Cited: 67

Sex differences in antipsychotic efficacy and side effects in schizophrenia spectrum disorder: results from the BeSt InTro study
Sanne Hoekstra, Christoffer Bartz‐Johannessen, Igne Sinkeviciute, et al.
Schizophrenia (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 50

The Involvement of Prolactin in Stress-Related Disorders
Agata Faron‐Górecka, Katarzyna Latocha, Paulina Pabian, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 4, pp. 3257-3257
Open Access | Times Cited: 21

The Direct and Long-Term Effects of Raloxifene as Adjunctive Treatment for Schizophrenia-Spectrum Disorders: A Double-Blind, Randomized Clinical Trial
Bodyl A. Brand, Janna N. de Boer, Machteld Marcelis, et al.
Schizophrenia Bulletin (2023) Vol. 49, Iss. 6, pp. 1579-1590
Open Access | Times Cited: 19

The role of cortisol and prolactin in the pathogenesis and clinical expression of psychotic disorders
Javier Labad
Psychoneuroendocrinology (2018) Vol. 102, pp. 24-36
Closed Access | Times Cited: 56

Hypothalamic-Pituitary-Ovarian Axis Reactivation by Kisspeptin-10 in Hyperprolactinemic Women With Chronic Amenorrhea
Robert P. Millar, Charlotte Sonigo, Richard A. Anderson, et al.
Journal of the Endocrine Society (2017) Vol. 1, Iss. 11, pp. 1362-1371
Open Access | Times Cited: 55

Prediction of conversion to psychosis in individuals with an at-risk mental state
Anita Riecher‐Rössler, Erich Studerus
Current Opinion in Psychiatry (2017) Vol. 30, Iss. 3, pp. 209-219
Closed Access | Times Cited: 54

Exacerbation of Psychosis During the Perimenstrual Phase of the Menstrual Cycle: Systematic Review and Meta-analysis
Thomas J. Reilly, Vanessa Charlotte Sagnay de la Bastida, Dan W. Joyce, et al.
Schizophrenia Bulletin (2019) Vol. 46, Iss. 1, pp. 78-90
Open Access | Times Cited: 51

Progression from being at-risk to psychosis: next steps
Jean Addington, Megan S. Farris, Daniel J. Devoe, et al.
Schizophrenia (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 48

The genetic architecture of the human hypothalamus and its involvement in neuropsychiatric behaviours and disorders
Shi-Dong Chen, Jia You, Wei Zhang, et al.
Nature Human Behaviour (2024) Vol. 8, Iss. 4, pp. 779-793
Closed Access | Times Cited: 5

Real-World Effectiveness of Menopausal Hormone Therapy in Preventing Relapse in Women With Schizophrenia or Schizoaffective Disorder
Bodyl A. Brand, I. Sommer, Shiral S. Gangadin, et al.
American Journal of Psychiatry (2024)
Closed Access | Times Cited: 5

Cognitive functions associated with developing prefrontal cortex during adolescence and developmental neuropsychiatric disorders
Takeshi Sakurai, Nao J. Gamo
Neurobiology of Disease (2018) Vol. 131, pp. 104322-104322
Closed Access | Times Cited: 42

Page 1 - Next Page

Scroll to top